U.S. is main growth driver as L’Oréal Q1 sales top estimates
Despite macroeconomic uncertainty, the company said it remains optimistic about its outlook.
Despite macroeconomic uncertainty, the company said it remains optimistic about its outlook.
The bill would prohibit a company from owning or controlling a pharmacy, PBM, and, in some cases, a health insurer within the state.
Investments in health services reflect the view of pharmacy as a clinical touchpoint and loyalty driver.
Katie Scanlon’s appointment to head the business reaffirms a focus on pharmacist-led care.
Consumers are increasingly turning to probiotics and digestive health solutions, reinforcing front-end growth opportunities for chain drug retailers.
“This isn’t about introducing something new, it’s about making visible what we’ve built,” said John Chang, CEO of Kiss Beauty Group.
Why pharmacy operators should rethink infrastructure before the next disruption hits.
This is a first-of-its-kind research partnership to improve skin health science, merging expertise in microbiology and immunology.
A new skincare brand from Hyundai Bioscience brings peptide-driven barrier care to mass-market price points, with all products under $25.
Oral GLP-1 therapy achieves double-digit weight loss in trials and launches this month with no food or water restrictions, expanding access through retail and direct-to-consumer channels.
The female-founded company secured investments from Kevin O’Leary and Robert Herjavec during the March 11 broadcast.
SHARx argues that without tackling rebate-driven economics and PBM decision-making power, efforts to lower drug prices may have limited impact on patients.
Numerator reports consumers are adjusting to new nutrition guidance, but increased grocery costs and ingrained habits restrict change.
Abbott CEO Robert B. Ford stated the merger improves global access to vital diagnostic tools.
The collaboration merges NVIDIA’s ALCHEMI framework with L’Oréal’s R&I ecosystem, allowing scientists to simulate ingredient interactions at the atomic level.
BoomRx’s platform consolidates access to products from both 503A compounding pharmacies and FDA-registered 503B outsourcing facilities.